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Abstract
Objective: To determine the clinical profi le of pregnant 
women with COVID-19 who hospitalized in a referral 
hospital.
Methods: This was a descriptive study conducted on 
pregnant women with COVID-19 who were hospitalized at 
Regional Hospital of Bau-Bau and Bahteramas Hospital in 
Southeast Sulawesi from May to July 2020. The confi rmation 
of COVID-19 was based on RT-PCR. Data including 
characteristics, clinical profi le, laboratory test, imaging, 
management, and outcomes.
Results: There were 41 pregnant women with COVID-19 and 
no maternal death cases. Maternal age was approximately 
19 to 39 years, had middle education levels, and was a 
housewife. Most of them did not know their closed contacts, 
had no comorbidities, and referrals from other hospitals. 
They were 3rd-trimester and hospitalized with complaints 
related to pregnancy. Only 3 cases had complaints related 
to COVID-19, namely fever and cough. The majority of 
laboratory tests were leucocytosis. Chest X-ray shows 
bronchopneumonia, pneumonia, and normal imaging. 
Obstetrics management was performed according to the 
condition of the mother and fetus, including dilatation and 
curretage vaginal delivery, cesarean section, and curettage. 
The treatment was using broad-spectrum antibiotics and 
antiviral. Adverse pregnancy outcome were miscarriage, 
fetal distress, LBW, and asphyxia.
Conclusions: Pregnant women with COVID-19 have mild 
or asymptomatic symptoms, hospitalized with complaints 
related to their pregnancy, and treatment according to the 
condition of the mother and fetus. There are no maternal 
complications, while fetal complications are not clear.
Keywords: COVID-19, pregnant women, referral hospital.
Abstrak
Tujuan: Mengetahui gambaran klinis ibu hamil dengan 
COVID-19 yang masuk di rumah sakit rujukan COVID-19.
Metode: Penelitian ini bersifat deskriptif yang dilakukan 
pada ibu hamil dengan COVID-19 yang dirawat di rumah 
sakit rujukan di Sulawesi Tenggara, yaitu RSUD Bau-Bau 
dan RSU Bahteramas di Kendari, pada bulan Mei sampai 
Juli 2020. Konfi rmasi positif COVID-19 berdasarkan hasil 
pemeriksaan RT-PCR. Data berupa karakteristik, gambaran 
klinis, pemeriksaan penunjang, penatalaksanaan, dan luaran. 
Hasil: Terdapat 41 ibu hamil dengan COVID-19 dan tidak 
ada kasus kematian ibu. Usia ibu berkisar 19-39 tahun, 
tingkat pendidikan menengah, dan sebagai ibu rumah 
tangga. Sebagian besar kasus pada trimester-3, tidak tahu 
memiliki kontak erat, tidak memiliki komorbid, dan rujukan 
dari RS lain. Sebagian besar dirawat dengan keluhan 
terkait kehamilannya dan hanya 3 kasus dengan keluhan 
terkait COVID-19, yaitu demam dan batuk. Pemeriksaan 
laboratorium menunjukkan lekositosis. Gambaran foto 
toraks menunjukkan bronkopneumonia, pneumonia, dan 
normal. Tindakan obstetri dilakukan atas indikasi ibu dan 
janin, yaitu persalinan normal, seksio sesarea, dan kuretase. 
Terapi yang digunakan adalah antibiotik spektrum luas dan 
antivirus. Komplikasi pada janin/bayi berupa abortus, gawat 
janin, BBLR, dan asfi ksia. 
Kesimpulan: Ibu hamil dengan COVID-19 memiliki gejala 
ringan atau asimtomatik, dirawat dengan keluhan terkait 
kehamilannya, dan dilakukan tindakan obstetri sesuai 
dengan indikasi ibu dan janin. Tidak ada komplikasi pada 
ibu, sedangkan komplikasi pada bayi belum jelas.
Kata kunci: COVID-19, ibu hamil, rumah sakit rujukan.
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Corona virus Disease 2019 (COVID-19) is a 
new disease in humans.1 Increasing the number 
of COVID-19 cases in Indonesia is taking quickly.2 
Currently, the spread of COVID-19 has reached 
all provinces in Indonesia, with an increasing 
number of cases and/or deaths.3
Coronaviruses are a large family of viruses that 
cause illness with mild to severe symptoms. Most 
at risk of contracting this disease are people 
who have close contact with COVID-19 patients, 
including those who treat COVID-19 patients. 
Several groups susceptible to being infected with 
COVID-19 are the elderly, children, and pregnant 
women.1,2
Pandemic has affected political, social, 
economic, public welfare, and culture in 
Indonesia, including affect anxiety in pregnant 
women.3,4 Knowledge about COVID-19 infection 
in pregnancy and the fetus is still limited, and 
there are no recommendations issued by the 
World Health Organization (WHO) for handling 
pregnant women with COVID-19. It is suspected 
that pregnant women with co-morbid have a 
higher risk of experiencing COVID-19 with severe 
symptoms, morbidity, and mortality compared to 
the general population. The fetal side effect of 
preterm delivery is also unclear whether it related 
to infection in the mother.3
 Therefore, this study aims to evaluate 
the pregnant women with COVID-19 who 
hospitalized in regional referral hospitals. This 
data can provide information to physicians about 
differences and variations in the clinical profi le of 
pregnant women with COVID-19.
METHODS
This was a descriptive study conducted on 
pregnant women with COVID-19 who admitted to 
referral hospitals in Southeast Sulawesi, Regional 
Hospital of Bau-Bau and Bahteramas Hospital, 
from May to July 2020. Positive confi rmation 
of COVID-19 based on the real-time reverse 
transcription-polymerase chain reaction (RT-
PCR) assay, which was the current gold standard 
for detecting SARS-CoV-2 from respiratory 
specimens in suspected COVID-19 patients.
The inclusion criteria were pregnant women 
who confi rmed positive for COVID-19 and 
had complete data. The data were fi lled in and 
reported by their doctor, including characteristics, 
clinical features, laboratory tests, imaging, 
management, and outcomes of maternal and 
infant. The characteristics of respondents 
comprised age, education, occupation, gravida, 
gestational age, history of close contact with 
COVID-19 patients, co-morbid, and referral. The 
clinical features including symptoms and signs 
related to pregnancy and related to COVID-19. 
The laboratory tests comprise hemoglobin 
levels, leucocytes, and platelets count. Imaging 
was performed with a chest X-ray. Management 
comprised treatment and drug administration. 
The infant outcome includes birth weight and the 
complication of the baby.
Statistical analysis used SPSS for windows 
Version-23 and was presented as frequency and 
percentage. The ethical clearance had approved 
by the Health Ethics Commission of Halu Oleo 
University.
RESULTS
There were 41 pregnant women who were 
confi rmed positive for COVID-19 who admitted 
at referral hospitals. There was no maternal death 
case. All cases had good maternal outcome. There 
were 35 babies, 5 cases without outcome babies, 
and one case with a good intrauterine fetal. The 
characteristics of pregnant women showed in 
Table-1.
Table 1 showed that the range of women ages 
was 19 to 39 years, and the majority was 26-
30 years (34.1%).  Most pregnant women were 
middle education levels (56.1%) and work as 
housewives (70.7%).
The COVID-19 cases were distributed in 
primigravida (29.3%) and multigravida (70.7%). 
Most of them were in the 3rd trimester (87.8%). 
Most pregnant women did not know the history 
of close contact, only 2 cases with close contact. 
Most of them were without comorbid, only 1 case 
with hypertension as comorbid. Most pregnant 
women have a referral from other hospitals 
(43.9%), primary health centers (26.8%), and 
doctor's clinic (9.8%). However, there were 19.5% 
cases without a reference.
Most of the complaints of pregnant women 
with COVID-19 were related to their pregnancy, 
including labor (68.3%) and bleeding (12.2%). 
However, there were 19.5% of cases had no 
complaints. Pregnant women with symptoms of 
COVID-19 were only 3 cases. They experienced 
fever, malaise, myalgia, and cough. There was 
none experienced shortness of breath.
Laboratory tests showed that most hemoglobin 
levels were> 10 g% (63.4%), had leukocytosis 
(73.2%), and the platelet count was normal in 
all cases. There were 4 cases with chest X-ray, 
comprise pneumonia (4.9%), bronchopneumonia 
(2.9%), and normal (2.9%).
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Variable Total Condition of the Fetus/Baby
Treatment was based on the indications of 
the mother and the fetus comprises dilatation 
and curettage(12.5%), vaginal delivery (47.5%), 
cesarean section (40.0%), and curettage (12.5%). 
Therapy in this study was using broad-spectrum 
antibiotics (87.8%) and anti-virus (12.2%). 
There were no maternal complications. Most 
of the birth weight was 2500-4000 (82.8%). The 
complications in the fetus were misscarriage 
(12.2%), fetal distress (4.9%), LBW (7.3%), and 
asphyxia (17.1%).
DISCUSSION
There was no death case of pregnant women 
with positive COVID-19 in this study. A study 
in the elderly found the number of death cases 
was 23%.5 This was increasing evidence that 
some COVID-19 patients have mild symptoms. 
However, the absence of symptoms can make it 
diffi cult for detecting an asymptomatic infection.6 
About 80% of COVID-19 infections are mild or 
asymptomatic; 15% severe, require supplemental 
oxygen; and 5% critical, requiring mechanical 
ventilation.1 Outcomes of maternal with 
COVID-19 appear to be better than SARS and 
MERS. The case fatality rate for COVID-19, SARS, 
and MERS was 0%, 18%, and 25%, respectively. 
The most common causes of death in SARS and 
MERS were progressive respiratory failure and 
severe sepsis.7-9
Positive cases of COVID-19 in this study were 
found in all gravida and most of them in the third 
trimester. This was similar to other studies which 
found that most pregnant women contracted 
COVID-19 in the third trimester.7 Almost all cases 
did not know the history of close contact with 
COVID-19 patients. They were diagnosed on 
admission with a rapid test followed by RT-PCR of 
an oropharyngeal swab. They were hospitalized 
with complaints related to their pregnancy and 
had referral letters from other hospitals, primary 
health centers, and doctors' clinics. Some of them 
had not a referral letter. It must be attention, that 
we must implement health protocols to prevent 
transmission because people without symptoms 
have the potential to transmit the virus. The 
COVID-19 can transmit through coughing/
sneezing droplets. Most at risk of contracting 
this disease were people who have close contact 
with COVID-19 patients, including those caring 
for COVID-19 patients.1,2
Fever, malaise, myalgia, and cough 
were symptoms of COVID-19 found in this 
study. There were no pregnant women who 
experienced shortness of breath. The clinical 
signs and symptoms of COVID-19 in most 
cases were fever, and some cases have diffi culty 
breathing.2 About 50% of elderly patients 
hospitalized with COVID-19 showed the classic 
symptoms of COVID-19, including fever, cough, 
and shortness of breath.5 Fever and cough were 
most symptoms of COVID-19 in both elderly and 
non-elderly patients.10 Changes in the immune 
and cardiorespiratory systems during pregnancy 
affected the susceptibility of pregnant women to 
severe infections and hypoxic disorders.11
In this study, we found leukocytosis and 
platelet counts were normal, different from other 
studies that found leucocytosis, lymphopenia, 
and thrombocytopenia.7 The chest X-ray was 
pneumonia, bronchopneumonia, and normal.  In 
most cases, the chest X-rays show pneumonia 
infi ltrate in both lungs.2 Chest imaging can help 
diagnose COVID-19, but do not replace molecular 
confi rmation of COVID-19. Chest imaging is 
nonspecifi c and appears similar in pregnancy.8,12
Treatment of pregnant women with 
COVID-19 in this study based on maternal and 
fetal indications, including curettage, vaginal 
delivery, and cesarean section.  Obstetric and 
clinical factors were to determine the decision 
of therapy. There is no conclusive evidence of 
vertical transmission, so vaginal delivery did 
not contraindicate in patients with COVID-19.12 
In emergency conditions, the cesarean section 
is carried out with caution, using complete 
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personal protective equipment and in the room 
with negative pressure ventilation.7,13
Broad-spectrum antibiotics and anti-viruses 
were given to the patients in this study. A recent 
study has identifi ed remdesivir and chloroquine 
as strong candidate drugs to treat COVID-19.14 
Remdesivir is a new widely acting nucleotide 
antiviral drug that inhibits the in vitro replication 
of SARS-CoV-2 and related coronaviruses, 
including the novel coronavirus 2019-nCov.15 Its 
use appears to be safe in pregnant women and 
phase 3 trials testing the effi cacy of COVID-19 
are currently underway in the United States and 
China. In a study with SARS patients, all patients 
were given broad-spectrum antibiotics, beta-
lactams, and macrolide or fl uoroquinolone.8
There were no maternal complications in this 
study. Abortions, fetal distress, LBW, and asphyxia 
were found, but it is not clear whether this is a 
complication of COVID-19 infection. SARS during 
pregnancy is associated with high incidences 
of spontaneous miscarriage, preterm delivery, 
and intrauterine growth restriction. There is no 
evidence of SARS infection among newborns to 
these mothers.8 There is no data that the increased 
risk of abortion associated with COVID-19 and it 
is also unclear whether COVID-19 infection can 
pass the transplacental route to the baby.3
CONCLUSION
Based on the results, we conclude that 
pregnant women with COVID-19 have mild or 
asymptomatic symptoms, hospitalized with 
signs and symptoms related to their pregnancy, 
and the management performed according to 
the mother and fetus indications. There are no 
maternal complications, and complications of the 
baby are not clear. Further research needs to be 
done with larger sample size and more complete 
variables.
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